Catherine Monet-Didailler1, Astrid Godron-Dubrasquet1, Iona Madden1, Yahsou Delmas2, Brigitte Llanas1, Jérôme Harambat3,4. 1. Service de Pédiatrie, Centre de référence Maladies Rénales Rares du Sud-ouest (SoRare), CHU de Bordeaux, Bordeaux, France. 2. Service de Néphrologie, Centre de référence Maladies Rénales Rares du Sud-ouest (SoRare), CHU de Bordeaux, Bordeaux, France. 3. Service de Pédiatrie, Centre de référence Maladies Rénales Rares du Sud-ouest (SoRare), CHU de Bordeaux, Bordeaux, France. jerome.harambat@chu-bordeaux.fr. 4. Inserm, Bordeaux Population Health Research Center, UMR 1219, Université de Bordeaux, Bordeaux, France. jerome.harambat@chu-bordeaux.fr.
Abstract
BACKGROUND: Hemolytic uremic syndrome due to Shiga toxin-producing E. coli (STEC-HUS) is the main cause of acute kidney injury in young children. Most fully recover kidney function; however, some develop long-term sequelae. We aimed to determine whether kidney injury 1 year after HUS onset is associated with long-term kidney outcome in pediatric STEC-HUS. METHODS: A retrospective population-based study of children < 15 years with STEC-HUS between 1992 and 2012 was performed. Mixed effects logistic regression was used to investigate associations between kidney injury at 1 year and long-term kidney outcome. RESULTS: Ninety-eight STEC-HUS cases were reported. Of 96 patients who survived acute phase, 84 were evaluated at 1-year follow-up of whom 42 (44% of survivors) showed ≥ 1 signs of kidney injury. Data from 81 patients were collected after median follow-up of 8.7 (IQR 3.5-12.7) years. At last follow-up, 42 (44% of survivors) had ≥ 1 signs of kidney injury including decreased estimated glomerular filtration rate (eGFR) < 90 mL/min/1.73 m2 (n = 30), proteinuria (n = 17), or hypertension (n = 5). Among 42 patients with kidney injuries at 1-year follow-up, only 22 (52%) still had kidney disease at last follow-up. Conversely, of 33 patients without kidney injury at 1-year and available long-term outcome data, 11 (33%) had proteinuria or decreased GFR at last follow-up. There was no statistically significant association between kidney injury at 1 year and long-term kidney outcome. CONCLUSIONS: Since kidney sequelae may appear at variable time intervals after acute HUS, all patients need lifelong follow-up to detect early signs of chronic kidney disease and propose measures to slow progression.
BACKGROUND:Hemolytic uremic syndrome due to Shiga toxin-producing E. coli (STEC-HUS) is the main cause of acute kidney injury in young children. Most fully recover kidney function; however, some develop long-term sequelae. We aimed to determine whether kidney injury 1 year after HUS onset is associated with long-term kidney outcome in pediatric STEC-HUS. METHODS: A retrospective population-based study of children < 15 years with STEC-HUS between 1992 and 2012 was performed. Mixed effects logistic regression was used to investigate associations between kidney injury at 1 year and long-term kidney outcome. RESULTS: Ninety-eight STEC-HUS cases were reported. Of 96 patients who survived acute phase, 84 were evaluated at 1-year follow-up of whom 42 (44% of survivors) showed ≥ 1 signs of kidney injury. Data from 81 patients were collected after median follow-up of 8.7 (IQR 3.5-12.7) years. At last follow-up, 42 (44% of survivors) had ≥ 1 signs of kidney injury including decreased estimated glomerular filtration rate (eGFR) < 90 mL/min/1.73 m2 (n = 30), proteinuria (n = 17), or hypertension (n = 5). Among 42 patients with kidney injuries at 1-year follow-up, only 22 (52%) still had kidney disease at last follow-up. Conversely, of 33 patients without kidney injury at 1-year and available long-term outcome data, 11 (33%) had proteinuria or decreased GFR at last follow-up. There was no statistically significant association between kidney injury at 1 year and long-term kidney outcome. CONCLUSIONS: Since kidney sequelae may appear at variable time intervals after acute HUS, all patients need lifelong follow-up to detect early signs of chronic kidney disease and propose measures to slow progression.
Authors: Robert S Oakes; Richard L Siegler; Markham A McReynolds; Theodore Pysher; Andrew T Pavia Journal: Pediatrics Date: 2006-05 Impact factor: 7.124
Authors: R T Krmar; J R Ferraris; J A Ramirez; S Ruiz; A Salomon; H M Galvez; J J Janson; C R Galarza; G Waisman Journal: Pediatr Nephrol Date: 2001-10 Impact factor: 3.714
Authors: Amit X Garg; Rita S Suri; Nick Barrowman; Faisal Rehman; Doug Matsell; M Patricia Rosas-Arellano; Marina Salvadori; R Brian Haynes; William F Clark Journal: JAMA Date: 2003-09-10 Impact factor: 56.272
Authors: Erin Hessey; Nabil Melhem; Rashid Alobaidi; Emma Ulrich; Catherine Morgan; Sean M Bagshaw; Manish D Sinha Journal: Front Pediatr Date: 2021-03-15 Impact factor: 3.418